Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

BUY
$4.7 - $9.87 $3.81 Million - $8 Million
810,957 Added 37.82%
2,955,230 $19.4 Million
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $635,038 - $892,805
69,479 Added 3.35%
2,144,273 $21.4 Million
Q2 2023

Jul 12, 2023

BUY
$12.09 - $15.0 $418,326 - $519,015
34,601 Added 1.7%
2,074,794 $25.8 Million
Q1 2023

May 02, 2023

BUY
$12.99 - $16.48 $5.04 Million - $6.4 Million
388,292 Added 23.51%
2,040,193 $28.6 Million
Q4 2022

Feb 06, 2023

BUY
$12.5 - $24.78 $12.4 Million - $24.6 Million
991,860 Added 150.27%
1,651,901 $23.6 Million
Q3 2022

Oct 18, 2022

BUY
$20.6 - $30.37 $13.6 Million - $20 Million
660,041 New
660,041 $16.9 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.